Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Revenue (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Revenue for 3 consecutive years, with $24.6 million as the latest value for Q1 2026.

  • Quarterly Revenue rose 62.7% to $24.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $83.7 million through Jan 2026, up 59.06% year-over-year, with the annual reading at $59.8 million for FY2025, 115.05% up from the prior year.
  • Revenue for Q1 2026 was $24.6 million at Kestra Medical Technologies, up from $22.6 million in the prior quarter.
  • The five-year high for Revenue was $24.6 million in Q1 2026, with the low at $8.3 million in Q1 2024.
  • Average Revenue over 3 years is $16.1 million, with a median of $15.1 million recorded in 2025.
  • Peak annual rise in Revenue hit 82.31% in 2025, while the deepest fall reached 51.55% in 2025.
  • Over 3 years, Revenue stood at $14.7 million in 2024, then skyrocketed by 53.4% to $22.6 million in 2025, then increased by 8.81% to $24.6 million in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $24.6 million, $22.6 million, and $19.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.